FEMASYS INC (FEMY) Stock News

USA - NASDAQ:FEMY - US31447E1055 - Common Stock

0.3495 USD

0 (-1.08%)

Last: 9/25/2025, 2:47:08 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

FEMY Latest News, Press Relases and Analysis

All

Press Releases

6 hours ago - By: Femasys Inc.

Femasys Accelerates European Growth for FemBloc® with Kebomed Partnership

6 hours ago - By: Femasys Inc.

Femasys Accelerates European Growth for FemBloc® with Kebomed Partnership

3 days ago - By: Femasys Inc.

Femasys Partners with Medical Electronic Systems to Launch FemSperm™ Analysis Kit for use with FemaSeed

3 days ago - By: Femasys Inc.

Femasys Partners with Medical Electronic Systems to Launch FemSperm™ Analysis Kit for use with FemaSeed

14 days ago - By: Femasys Inc.

Femasys Expands FemSperm™ Product Line with New Insemination Prep Kit to Broaden Gynecology-Based Access to FemaSeed®

14 days ago - By: Femasys Inc.

Femasys Expands FemSperm™ Product Line with New Insemination Prep Kit to Broaden Gynecology-Based Access to FemaSeed®

17 days ago - By: Femasys Inc.

Femasys Secures Regulatory Approval for FemBloc® Permanent Birth Control in New Zealand

17 days ago - By: Femasys Inc.

Femasys Secures Regulatory Approval for FemBloc® Permanent Birth Control in New Zealand

23 days ago - By: Femasys Inc.

Femasys Closes $8 Million in Financing to Accelerate Commercialization of Fertility and Birth Control Portfolios

23 days ago - By: Femasys Inc.

Femasys Closes $8 Million in Financing to Accelerate Commercialization of Fertility and Birth Control Portfolios

a month ago - By: Yahoo Finance

Femasys (FEMY) Falls 27% as Firm to Raise $8-Million from Share Sale

a month ago - By: Benzinga - Mentions: EPIX WORX THAR NLSP ...

12 Health Care Stocks Moving In Tuesday's Intraday Session

a month ago - By: Benzinga - Mentions: EPIX SATS ECX DOMO ...

Crude Oil Down 2%; US Durable Goods Orders Decline In July

a month ago - By: Femasys Inc.

Femasys Announces Pricing of $8.0 Million Underwritten Public Offering

a month ago - By: Femasys Inc.

Femasys Announces Pricing of $8.0 Million Underwritten Public Offering

a month ago - By: Femasys Inc.

Femasys Announces FemSperm™ Kit to Activate Gynecologists and Advance FemaSeed® Fertility Platform

a month ago - By: Femasys Inc.

Femasys Announces FemSperm™ Kit to Activate Gynecologists and Advance FemaSeed® Fertility Platform

a month ago - By: Femasys Inc.

Femasys Secures UK Regulatory Approval of FemBloc Permanent Birth Control

a month ago - By: Femasys Inc.

Femasys Secures UK Regulatory Approval of FemBloc Permanent Birth Control

2 months ago - By: The Motley Fool

Femasys Revenue Jumps 85 Percent in Q2

2 months ago - By: Zacks Investment Research - Mentions: GRAL

Femasys Inc. (FEMY) Reports Q2 Loss, Lags Revenue Estimates

2 months ago - By: Femasys Inc.

Femasys Announces Second Quarter Financial Results for 2025

2 months ago - By: Femasys Inc.

Femasys Announces Second Quarter Financial Results for 2025

2 months ago - By: Zacks Investment Research - Mentions: DTIL

Precision BioSciences (DTIL) Reports Q2 Loss, Lags Revenue Estimates

2 months ago - By: Zacks Investment Research - Mentions: VIR

Vir Biotechnology, Inc. (VIR) Reports Q2 Loss, Lags Revenue Estimates

2 months ago - By: Femasys Inc.

Femasys Secures First European Order for FemBloc, Marking Strategic Milestone in Global Expansion

2 months ago - By: Femasys Inc.

Femasys Secures First European Order for FemBloc, Marking Strategic Milestone in Global Expansion

3 months ago - By: Femasys Inc.

Femasys Achieves Australian and New Zealand Regulatory Approvals for FemaSeed® for First-Line Infertility Treatment and FemVue Diagnostic

3 months ago - By: Femasys Inc.

Femasys Achieves Australian and New Zealand Regulatory Approvals for FemaSeed® for First-Line Infertility Treatment and FemVue Diagnostic

3 months ago - By: Femasys Inc.

Femasys Announces Historic Milestone with European Approval of FemBloc®, the First Non-Surgical Permanent Birth Control

3 months ago - By: Femasys Inc.

Femasys Announces Historic Milestone with European Approval of FemBloc®, the First Non-Surgical Permanent Birth Control

3 months ago - By: Femasys Inc.

Femasys Names New Chief Commercial Officer to Drive Execution and Global Growth